Last checked at 31 Jan 2020 09:31
UK BROKER RATINGS SUMMARY: HSBC Downgrades BT To Hold From Buy
UK BROKER RATINGS SUMMARY: HSBC Downgrades BT To Hold From Buy
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat
GSK Share
Trades1
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,636.00
Bid:
1,538.00
Ask:
1,700.00
Change:
0.00 (0.00%)
Spread:
162.00 (10.533%)
Open:
0.00
High:
0.00
Low:
0.00
Prev. Close:
1,636.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.30 Jan 2020 10:55
MITIE Revenue Grows In First Nine Months But Flat On Organic Basis
MITIE Revenue Grows In First Nine Months But Flat On Organic Basis
Read more30 Jan 2020 09:45
UPDATE 3-EU court sets criteria for GSK case on 'pay-for-delay' drug deals
(Adds CMA reaction, paragraphs 6-7)BRUSSELS, Jan 30 (Reuters) - The European Union's top court set criteria on Thursday to resolve a dispute in Britain over deals GlaxoSmithKline struck with rival drugmakers to delay the launch of generic drugs.Th...
Read more30 Jan 2020 09:45
UPDATE 2-EU court sets criteria for GSK case on 'pay-for-delay' drug deals
(Adds GSK reaction)BRUSSELS, Jan 30 (Reuters) - The European Union's top court set criteria on Thursday to resolve a dispute in Britain over deals GlaxoSmithKline struck with rival drugmakers to delay the launch of generic drugs.The court said the...
Read more30 Jan 2020 09:45
UPDATE 1-EU court sets criteria for GSK case on "pay-for-delay" drug deals
(Adds court comments, background)BRUSSELS, Jan 30 (Reuters) - The European Union's top court set criteria on Thursday to resolve a dispute in Britain over deals GlaxoSmithKline struck with rival drugmakers to delay the launch of generic drugs.The ...
Read more30 Jan 2020 08:55
EU court sets criteria for GSK case on "pay-for-delay" drug deals
BRUSSELS, Jan 30 (Reuters) - The European Union's top court set criteria on Thursday to resolve a dispute in Britain over deals GlaxoSmithKline struck with rival drug makers to delay the launch of generic drugs.The court said these deals in themse...
Read more30 Jan 2020 07:00
INSIGHT-On eve of Brexit, Britain faces critical test to defend drug trial crown
* Britain plays leading role in pan-EU drug trials* It is European leader in early-stage research* Scientists fear UK could lose its preeminent role* Industry fears talented workers could leave Britain* Some execs say Brexit could speed up approval s...
Read more29 Jan 2020 16:08
UK Earnings, Trading Statements Calendar - Next 7 Days
UK Earnings, Trading Statements Calendar - Next 7 Days
Read more28 Jan 2020 17:07
LIVE MARKETS-Closing snapshot: What a recovery
* European shares up after big pullback on virus scare * STOXX 600 now up 0.8%, FTSE 100 up 0.4% * Wall Street recovers Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporter...
Read more28 Jan 2020 15:59
LIVE MARKETS-About the BoE's 50-50 cliffhanger
* European shares up after big pullback on virus scare * STOXX 600 now up 0.8%, FTSE 100 up 0.4% * Wall Street recovers Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporter...
Read more28 Jan 2020 13:41
LIVE MARKETS-Stocks: Who will party on Brexit Friday?
* European shares up after big pullback on virus scare * STOXX 600 edges 0.3% higher, FTSE 100 up 0.4% * Wall Street set to recover Welcome to the home for real-time coverage of European equity markets brought to you by Reuters st...
Read more27 Jan 2020 15:03
Glaxo Licenses Tuberculosis Vaccine To Bill Gates Research Institute
Glaxo Licenses Tuberculosis Vaccine To Bill Gates Research Institute
Read more22 Jan 2020 15:03
Roche wins approval for cancer drug Kadcyla in fast-growing China market
* China approves import of Kadcyla drug for breast cancer* Kadcyla surpassed $1 billion in annual sales last year* China is Roche's second-largest market behind the United StatesBy Roxanne Liu and John MillerBEIJING/ZURICH Jan 22 (Reuters) - Roche s...
Read more22 Jan 2020 12:52
Wednesday broker round-up
(Sharecast News) - Experian: Morgan Stanley upgrades to overweight with a target price of 2,950p.
Read more22 Jan 2020 09:51
UPDATE 1-GSK appeal against fine over 'pay-for-delay' drug deals faces EU rebuke
(adds details, background)BRUSSELS, Jan 22 (Reuters) - British drugmaker GlaxoSmithKline may have harmed competition with payments it made to generic drugmakers to delay the launch of cheap copies of an antidepressant, according to an adviser to ...
Read more